Mostrar el registro sencillo del ítem

Artículo

dc.creatorLarramona Arcas, Raqueles
dc.creatorGonzález Arias, Candelaes
dc.creatorPerea, Gertrudises
dc.creatorGutiérrez, Antoniaes
dc.creatorVitorica Ferrández, Francisco Javieres
dc.creatorGarcía Barrera, Tamaraes
dc.creatorGómez Ariza, José Luises
dc.creatorPascua Maestro, Raqueles
dc.creatorGanfornina, María Doloreses
dc.creatorKara, Eleannaes
dc.creatorMartínez Vicente, Martaes
dc.date.accessioned2020-07-02T07:31:01Z
dc.date.available2020-07-02T07:31:01Z
dc.date.issued2020
dc.identifier.citationLarramona Arcas, R., González Arias, C., Perea, G., Gutiérrez, A., Vitorica Ferrández, F.J., García Barrera, T.,...,Martínez Vicente, M. (2020). Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice. Molecular Neurodegeneration, art. 35, 1-23.
dc.identifier.issn1750-1326es
dc.identifier.urihttps://hdl.handle.net/11441/98631
dc.description.abstractBackground The apolipoprotein E (APOE) gene exists in three isoforms in humans: APOE2, APOE3 and APOE4. APOE4 causes structural and functional alterations in normal brains, and is the strongest genetic risk factor of the sporadic form of Alzheimer’s disease (LOAD). Research on APOE4 has mainly focused on the neuronal damage caused by defective cholesterol transport and exacerbated amyloid-β and Tau pathology. The impact of APOE4 on non-neuronal cell functions has been overlooked. Astrocytes, the main producers of ApoE in the healthy brain, are building blocks of neural circuits, and Ca2+ signaling is the basis of their excitability. Because APOE4 modifies membrane-lipid composition, and lipids regulate Ca2+ channels, we determined whether APOE4 dysregulates Ca2+signaling in astrocytes. Methods Ca2+ signals were recorded in astrocytes in hippocampal slices from APOE3 and APOE4 gene targeted replacement male and female mice using Ca2+ imaging. Mechanistic analyses were performed in immortalized astrocytes. Ca2+ fluxes were examined with pharmacological tools and Ca2+ probes. APOE3 and APOE4 expression was manipulated with GFP-APOE vectors and APOE siRNA. Lipidomics of lysosomal and whole-membranes were also performed. Results We found potentiation of ATP-elicited Ca2+responses in APOE4 versus APOE3 astrocytes in male, but not female, mice. The immortalized astrocytes modeled the male response, and showed that Ca2+ hyperactivity associated with APOE4 is caused by dysregulation of Ca2+ handling in lysosomal-enriched acidic stores, and is reversed by the expression of APOE3, but not of APOE4, pointing to loss of function due to APOE4 malfunction. Moreover, immortalized APOE4 astrocytes are refractory to control of Ca2+ fluxes by extracellular lipids, and present distinct lipid composition in lysosomal and plasma membranes. Conclusions Immortalized APOE4 versus APOE3 astrocytes present: increased Ca2+ excitability due to lysosome dysregulation, altered membrane lipidomes and intracellular cholesterol distribution, and impaired modulation of Ca2+ responses upon changes in extracellular lipids. Ca2+ hyperactivity associated with APOE4 is found in astrocytes from male, but not female, targeted replacement mice. The study suggests that, independently of Aβ and Tau pathologies, altered astrocyte excitability might contribute to neural-circuit hyperactivity depending on APOE allele, sex and lipids, and supports lysosome-targeted therapies to rescue APOE4 phenotypes in LOAD.es
dc.formatapplication/pdfes
dc.format.extent23 p.es
dc.language.isoenges
dc.publisherBMCes
dc.relation.ispartofMolecular Neurodegeneration, art. 35, 1-23.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAPOE4es
dc.subjectAstrocyteses
dc.subjectCalcium signalinges
dc.subjectSexes
dc.subjectLysosomees
dc.subjectPurinergic receptorses
dc.subjectLipidomees
dc.titleSex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement micees
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Bioquímica y Biología Moleculares
dc.relation.publisherversionhttp://dx.doi.org/10.1186/s13024-020-00382-8es
dc.identifier.doi10.1186/s13024-020-00382-8es
dc.journaltitleMolecular Neurodegenerationes
dc.publication.issueart. 35es
dc.publication.initialPage1es
dc.publication.endPage23es

FicherosTamañoFormatoVerDescripción
s13024-020-00382-8.pdf4.329MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional